Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
94.96
(
-6.14%
)
Bitcoin
76,576.18
(
-0.90%
)
News Focus
News Focus
Post# of 236691
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Amatuer17

Send PM Follow Ignore
Followers 77
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Amatuer17

Re: Zuess421 post# 44931

Thursday, 08/15/2019 7:08:47 AM

Thursday, August 15, 2019 7:08:47 AM

Post# of 236691
Worth reading

“We currently anticipate that, absent patent term extension, patent protection relating to the PRO 140 antibody itself will start to expire in 2023, certain methods of using PRO 140 for treatment of HIV-1 will start to expire in 2026, certain formulations comprising PRO 140 will start to expire in 2031, and certain methods of using small-molecule CCR5 antagonists for treatment of cancer metastasis will start to expire in 2032.”

The basic patent starts expiring in 4 years - that is one of the reasons many BP are not touching it

Also they have to pay royalties to Progenics and AbbVie - 8.5% plus milestone payments - $5 million after 1st approval to progenics
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CYDY News
More CYDY News